Masimo (MASI) Receives a Buy from Wells Fargo
In a report released today, Vik Chopra from Wells Fargo maintained a Buy rating on Masimo, with a price target of $190.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Chopra is a 3-star analyst with an average return of 6.4% and a 44.19% success rate. Chopra covers the Healthcare sector, focusing on stocks such as Alphatec Holdings, Globus Medical, and Masimo.
In addition to Wells Fargo, Masimo also received a Buy from Piper Sandler’s Jason Bednar in a report issued yesterday. However, on the same day, TipRanks – OpenAI reiterated a Hold rating on Masimo (NASDAQ: MASI).
Based on Masimo’s latest earnings release for the quarter ending September 27, the company reported a quarterly revenue of $371.5 million and a GAAP net loss of $100.4 million. In comparison, last year the company earned a revenue of $504.6 million and had a net profit of $9.8 million
Read More on MASI:
Disclaimer & DisclosureReport an Issue
- Masimo: Strong Q4 Beat, Upgraded 2025 Outlook, and Expanding Driver Shipments Underpin Buy Rating
- Masimo Issues Strong Preliminary Results for 2025 Performance
- Masimo reports preliminary FY25 EPS at least $5.55, consensus $5.48
- Masimo reports preliminary Q4 EPS at least $1.54, consensus $1.46
- Masimo’s Pediatric SpO2 Study With Philips Monitors: What Investors Should Watch
